Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Prepaid Assets (2022 - 2025)

Historic Prepaid Assets for Zentalis Pharmaceuticals (ZNTL) over the last 4 years, with Q3 2025 value amounting to $10.8 million.

  • Zentalis Pharmaceuticals' Prepaid Assets fell 2608.87% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year decrease of 2608.87%. This contributed to the annual value of $14.4 million for FY2024, which is 3015.96% down from last year.
  • As of Q3 2025, Zentalis Pharmaceuticals' Prepaid Assets stood at $10.8 million, which was down 2608.87% from $11.4 million recorded in Q2 2025.
  • Over the past 5 years, Zentalis Pharmaceuticals' Prepaid Assets peaked at $27.2 million during Q1 2023, and registered a low of $10.8 million during Q3 2025.
  • Moreover, its 4-year median value for Prepaid Assets was $20.1 million (2023), whereas its average is $19.1 million.
  • In the last 5 years, Zentalis Pharmaceuticals' Prepaid Assets soared by 2458.55% in 2023 and then crashed by 4325.51% in 2025.
  • Quarter analysis of 4 years shows Zentalis Pharmaceuticals' Prepaid Assets stood at $24.3 million in 2022, then decreased by 15.1% to $20.6 million in 2023, then crashed by 30.16% to $14.4 million in 2024, then dropped by 24.92% to $10.8 million in 2025.
  • Its Prepaid Assets stands at $10.8 million for Q3 2025, versus $11.4 million for Q2 2025 and $13.8 million for Q1 2025.